IMEXF (Imagin Medical) OCF Margin %: 0.00% (As of Jun. 2023)


What is Imagin Medical OCF Margin %?

Imagin Medical IMEXF -99.00% OCF Margin % is 0.00% as of Jun. 2023.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Imagin Medical's Cash Flow from Operations for the three months ended in Jun. 2023 was $0.01 Mil. Imagin Medical's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Imagin Medical's OCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Imagin Medical's current OCF Yield % is -400,600.00%.

The historical rank and industry rank for Imagin Medical's OCF Margin % or its related term are showing as below:


IMEXF's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86
* Ranked among companies with meaningful OCF Margin % only.

Imagin Medical OCF Margin % Related Terms

Imagin Medical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Imagin Medical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical OCF Margin % Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagin Medical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Imagin Medical's OCF Margin for the fiscal year that ended in Sep. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2022 )/Revenue (A: Sep. 2022 )
=-1.969/0
= %

Imagin Medical's OCF Margin for the quarter that ended in Jun. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=0.014/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Imagin Medical (IMEXF) has a OCF Margin % of 0.00% as of Jun. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Imagin Medical and its competitors.
Is Imagin Medical's OCF Margin % too high?
Imagin Medical's current OCF Margin % is 0.00%.
How does Imagin Medical's OCF Margin % compare to ABT and SYK?
Imagin Medical's OCF Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Imagin Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imagin Medical's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current OCF Margin % is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.